This,
if their claims are true, will likely work. I read through the research section and its subpages. They claim that their agent is able to
reverse fibrosis:
A compound is delivered to the layer of follicles, 3-4 mm below the surface of the scalp, that reverses the inflammation, increases blood flow and then enriches hair follicles with the very combination of nutrients, vitamins and minerals normally delivered by the body.
The nutrients stuff is not really interesting, because nutrients are not the key problem. Many nutrient-based solutions exist and all of them don't work. According to their patent, they deploy a vasodilator in their drug, i.e. that covers the "increases blood flow" claim and is what minoxidil already does.
Their explanation, "nutrient deficiency syndrome" is also wrong as far as recent research is concerned. But that doesn't matter, because the effect which would make their drug work is not the nutrient supply, but the reversing of fibrosis.
So the interesting part is their claim that they're able to
reverse perifollicular fibrosis. That would be a major breakthrough and, on top of that, would also treat male pattern baldness (which leads to perifollicular fibrosis) and allow for regrowth.
The only question is if their claim that they're able to reverse fibrosis if true. If it is, their treatment will very likely work. The other factors, i.e. the nutrients and the vasodilator, are not really of importance - we already have that and know of its limited efficacy.
And for those wondering about then it will be available in the western world:
Biologix attorneys estimate the regulatory agency approval process to require two to four years once application has been made.
[...]
This phase of R&D (note for context: the phase before FDA application can be filed) is expected to be completed before the end of the first quarter, 2014.
Most of you know how slow the medical authorities work. I wouldn't expect the treatment to be available in the US, Canada, or Europe before 2018, assuming the longer estimate of 4 years made by the company.
Edit: Never mind this post. I should've read more carefully. They state they are able to reverse inflammation, but not fibrosis. This means they can only provide limited regrowth, i.e. in areas that are currently struck by inflammation which will ultimately lead to fibrosis. They can thus save the areas not yet struck by fibrosis by resetting the inflammation process back to zero, to a point before it triggers stronger fibrosis. But fibrosis itself will - at least according to the information they have made public, can't say anything about the non-public parts - not be reverted, i.e. no regrowth in areas that are already slick bald. Let's hope they have something up their sleeves they haven't made public.